Legalization of Psychedelic Substances
Luke A. Downey, Jerome Sarris, Daniel Perkins
JAMA December 21, 2021 DOI: 10.1001/jama.2021.19372 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Peer reviewed |
|---|---|
| Keywords | Family medicine Otorhinolaryngology |
| Citations | 8 |
Abstract
Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Citations in the library
Cited by 6
- Psychedelic Commercialization: A Wide-Spanning Overview of the Emerging Psychedelic Industry. Psychedelic Medicine September 13, 2023
- Disruptive innovation in psychiatry Annals of the New York Academy of Sciences March 1, 2022
- The historical opposition to psychedelic research and implications for credibility in psychiatry. CNS Spectrums November 21, 2024
- With great power comes great responsibility: Promise and caution in the new psychedelic renaissance Brain Disorders September 23, 2025
- Psychedelic Ethics Philosophy Compass September 1, 2025
and 1 more in the library
Cites 3
- Trial of Psilocybin versus Escitalopram for Depression New England Journal of Medicine April 14, 2021
- Two Models of Legalization of Psychedelic Substances: Reasons for Concern. JAMA August 1, 2021
- Medicinal psychedelics for mental health and addiction: Advancing research of an emerging paradigm Australian & New Zealand Journal of Psychiatry March 21, 2021